SCHEMBL20127460

SCHEMBL20127460

c1ccc2cc(-c3ccc4cc(-c5c6ccccc6c(-c6c7ccccc7cc7c6oc6ccccc67)c6ccccc56)ccc4c3)ccc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 1/20 0.39
ALOX5 P09917 3/20 0.39
CYP1B1 Q16678 2/20 0.38
CYP1A1 P04798 1/20 0.38
AHR P35869 1/20 0.38
CYP1A2 P05177 3/20 0.38
CYP2C9 P11712 3/20 0.38
CYP2C19 P33261 2/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
ESR1 P03372 1/20 0.36
ESR2 Q92731 1/20 0.36
HSD17B1 P14061 2/20 0.34
HSD17B2 P37059 2/20 0.34
ALDH1A1 P00352 2/20 0.33
HSD17B10 Q99714 2/20 0.33
HIF1A Q16665 1/20 0.33
PIK3CD O00329 1/20 0.33
XRCC6 P12956 1/20 0.33
XRCC5 P13010 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10122559 0.99 GPR84 (0.40) GPR84ALOX5CYP1B1CYP1A1AHR
SCHEMBL10122553 0.96 HSD17B1 (0.38) GPR84ALOX5CYP1B1CYP1A1AHR
SCHEMBL10122576 0.96 GPR84 (0.39) GPR84ALOX5CYP1B1CYP1A1AHR
SCHEMBL17944060 0.95 ESR1 (0.39) GPR84ALOX5CYP1B1CYP1A1AHR
SCHEMBL10122594 0.94 GPR84 (0.41) GPR84ALOX5CYP1B1CYP1A1AHR
SCHEMBL17931927 0.93 ESR1 (0.38) GPR84ALOX5CYP1B1CYP1A1AHR
SCHEMBL20127400 0.93 GPR84 (0.39) GPR84ALOX5CYP1B1CYP1A1CYP1A2
SCHEMBL20127396 0.93 CYP1B1 (0.40) GPR84ALOX5CYP1B1CYP1A1CYP1A2
SCHEMBL10122577 0.93 GPR84 (0.40) GPR84ALOX5CYP1B1CYP1A1AHR
SCHEMBL22180699 0.93 HCRTR1 (0.39) GPR84ALOX5CYP1B1CYP1A1AHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 GPR84 2389/4885ALOX5 4115/4885CYP1B1 341/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.